The largest database of trusted experimental protocols

Synergy ht detector

Manufactured by Agilent Technologies

The Synergy HT detector is a high-throughput microplate reader designed for a variety of applications. It provides quantitative measurements of absorbance, fluorescence, and luminescence signals in multi-well microplates.

Automatically generated - may contain errors

6 protocols using synergy ht detector

1

Quantitative Immunoglobulin ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Coating antibodies for binding IgA, IgM and IgG1 were purchased from Southern Biotechnology Associates (key resources table). Isotype standards used to calculate absolute concentration values are listed in the key resources table. HRP-labeled secondary antibodies for detecting IgA, IgM and IgG1 were purchased are listed in the key resources table. eBioscience ELISA diluent (no. 00-4202-56) was used as blocking buffer, TMB substrate (no. 00-4201-56) was used to develop, and 1 M phosphoric acid was used to stop development. Plates were read at 450 nm on a BioTek Synergy HT detector. Absolute concentrations of serum Abs were determined by interpolation from the standard curve, with attention paid to keeping values within standard and sample linear ranges. All samples were analyzed in duplicate over an eight-step dilution series.
+ Open protocol
+ Expand
2

Quantifying Antibody Isotype Profiles

Check if the same lab product or an alternative is used in the 5 most similar protocols
Coating antibodies for binding IgM, IgG1, IgG2a, IgG2b, IgG3, and IgA were purchased from Southern Biotech (#1020-01, 1070-01, 1080-01, 1090-01, 1100-01, and 1040-01 respectively). Coating antibody for detecting IgE was purchased from BD Pharmingen (#553413). The following isotype standards were used to calculate absolute concentration values: IgM (#14-4752-81; eBioscience), IgG1 (#0102-01; Southern Biotech), IgG2a (#M5409; Sigma), IgG2b (#M5534; Sigma), IgG3 (#553486, BD Pharmingen), IgA (#553478; BD Pharmingen), IgE (#557080; BD Pharmingen). Secondary antibodies for detecting IgM, IgG1, IgG2a, IgG2b, IgG3, IgA, IgE were purchased from Southern Biotech (#1020-05, 1070-05, 1080-05, 1090-05, 1100-05, 1040-05, and 1130-05 respectively). BSA-conjugated NP(8 (link)) [#N-5050l-10] and NP(30 (link)) [#N-5050H-10] were obtained from Biosearch Technologies. Plates were read at 450nm on a Biotek Synergy HT detector.
+ Open protocol
+ Expand
3

Cytotoxicity Evaluation of Biomaterial Scaffolds

Check if the same lab product or an alternative is used in the 5 most similar protocols
An MTT test ((3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)) was used to indirectly analyze the cytotoxicity of the different scaffolds. Rounded scaffold (d = 11 mm) were immersed in 5 ml of FBS-free culture medium and incubated at 37°C. Thermanox® (TMX) discs (Nunc®, Thermofisher) were used as negative control. Aliquots of the supernatant medium were taken at 1, 2, 7, 14 and 21 days under sterile conditions and replaced with fresh medium. The samples were kept frozen until use. hObs and hACs were seeded separately in a 96-well plate at 9 × 104 cells/ml of density and incubated for 24 h in complete medium. Then, the medium was substituted by the extracts and incubated at 37°C. After 24 h the medium was replaced by a solution of MTT (0.5 mg/ml) in warm FBS-free medium and the cells were incubated at 37°C for 3–4 h. Mediua containing MTT were removed and DMSO was added to dissolve the formazan crystals formed in the cells. The absorbance of the medium was measured with a Biotek Synergy HT detector at 570 nm and a reference wavelength of 630 nm. Cell viability was calculated as: CellViability%=100×ODSODB/ODCODB where ODS , ODB and ODC are the optical density (OD) of formazan production for the sample, blank and control, respectively.
+ Open protocol
+ Expand
4

Fluorometric Assay for Deubiquitinase Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ub-AMC was diluted in Gel filtration buffer to 400 nM. For each reaction 100 µL of diluted substrate in a black 96-well low volume plate (Corning) was mixed with 100 µL of 4 µM DUBs (40 nM for UCHL3) at room temperature. The rate of AMC generation was measured using a Synergy HT detector (Biotek). Fluorescent intensities were recorded following excitation at 340 nm and emission at 440 nm.
+ Open protocol
+ Expand
5

Quantitative Immunoglobulin ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Coating antibodies for binding IgA, IgM and IgG1 were purchased from Southern Biotechnology Associates (key resources table). Isotype standards used to calculate absolute concentration values are listed in the key resources table. HRP-labeled secondary antibodies for detecting IgA, IgM and IgG1 were purchased are listed in the key resources table. eBioscience ELISA diluent (no. 00-4202-56) was used as blocking buffer, TMB substrate (no. 00-4201-56) was used to develop, and 1 M phosphoric acid was used to stop development. Plates were read at 450 nm on a BioTek Synergy HT detector. Absolute concentrations of serum Abs were determined by interpolation from the standard curve, with attention paid to keeping values within standard and sample linear ranges. All samples were analyzed in duplicate over an eight-step dilution series.
+ Open protocol
+ Expand
6

Kinase Inhibition Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The kinase assays were performed using the KinaseGlo® reagent from Promega. All reactions were done in 50 μl volume. The buffer used for all kinase assays was 10 mm Tris-HCl, pH 7.4, 150 mm NaCl, 1 mm DTT, and 1 mm MgCl2. Drugs in 5 mm DMSO were diluted in kinase buffer to 1/2 the final concentration using a serial dilution from 20 to 0 μm. The final DMSO concentration in the reactions was no more than 0.4%. PrkA(1–338) was added to the drugs to a final concentration of 2.0 μm and allowed to incubate for 10 min at 37 °C. ATP and MBP (Novatein Biosciences, Woburn, MA) were added for a final concentration of 100 and 40 μm, respectively, initializing the reaction. After a half-hour incubation, the reaction was stopped by the addition of 50 μl of KinaseGlo® reagent, and the signal was allowed to stabilize for 10 min at room temperature per the product manual. The plate was read using luminescence detection on a Synergy HT detector (BioTek) and the data were collected using the Gen5 2.0 software (BioTek). The data were transformed to log scale and non-linear regression was performed in PRISM using the variable slope 4-parameter model for enzyme inhibition to determine IC50.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!